https://glucosylceramidesyn-re....ceptor.com/index.php
Studies conducted previously have confirmed miR-206's contribution to inflammatory cardiomyopathy, but its precise mode of action remains a subject of research. The investigation into the potential mechanistic effects of miR-206 on septic cardiomyopathy (SCM) is the central focus of this study. In vitro, primary mouse cardiomyocytes were subjected to lipop
Like
Comment
Share
